Introducing HFX for PDN. Finally, a nonpharmacologic approved to treat painful diabetic neuropathy.
86% of patients have substantial, durable pain relief1
77% average pain relief at 12-months1
92% of patients were satisfied with their treatment2
What an endocrinologist has to say about HFX for PDN
Finally, there’s a treatment option for PDN patients refractory to conventional medical management (CMM).
SCS is a well-established approach to managing chronic pain
The HFX Solution uses 10 kHz Therapy to activate inhibitory neurons in the dorsal horn, calming abnormal pain signals to the brain.
68% of patients demonstrated neurologic improvements1
Such as motor strength, reflexes, or sensory function.
Proven safe and effective for patients with diabetes1
At 12 months, 8 of 152 patients receiving 10 kHz therapy (5.2%) experienced infections.
Frequently asked questions
How do my patients access SCS?
HFX is covered under private health insurance. The level and waiting periods may vary depending on the provider, so we recommend you speak with your healthcare professional or a pain specialist to first determine if HFX is right for you.